Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin
Clinical trial NCT04387461 · COMPLETED
Trial details
- NCT number
- NCT04387461
- Sponsor
- CG Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2023-03-07
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.